BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7589072)

  • 21. Abnormal anterior chamber associated immune deviation (ACAID) in 129-strain mice.
    Herndon J; Gibler TS; Ferguson TA; Van Gelder RN
    Ocul Immunol Inflamm; 2006 Feb; 14(1):7-12. PubMed ID: 16507485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY; Mellon J
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gammadelta T cells in anterior chamber-induced tolerance in CD8(+) CTL responses.
    Xu Y; Kapp JA
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3473-9. PubMed ID: 12407158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen.
    Ferguson TA; Herndon JM
    Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3085-93. PubMed ID: 8206727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID.
    Geiger K; Sarvetnick N
    J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.
    Li XY; D'Orazio LT; Niederkorn JY
    Immunology; 1996 Sep; 89(1):34-40. PubMed ID: 8911137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
    D'Orazio TJ; Niederkorn JY
    J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anterior chamber associated immune deviation induced by TNP-splenocytes (TNP-ACAID). I. Systemic tolerance mediated by suppressor T-cells.
    Waldrep JC; Kaplan HJ
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1086-92. PubMed ID: 6192107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties.
    Wilbanks GA; Streilein JW
    Reg Immunol; 1992; 4(3):130-7. PubMed ID: 1303096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases.
    Niederkorn JY; Streilein JW
    J Immunol; 1982 Jun; 128(6):2470-4. PubMed ID: 6804562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
    Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of immune deviation elicited by antigens injected into the subretinal space.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
    Wilbanks GA; Mammolenti M; Streilein JW
    J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens.
    Williamson JS; Streilein JW
    Reg Immunol; 1988; 1(1):15-23. PubMed ID: 2978942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immune response and the eye: a role for TNF alpha in anterior chamber-associated immune deviation.
    Ferguson TA; Herndon JM; Dube P
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2643-51. PubMed ID: 8163352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous system.
    Li X; Taylor S; Zegarelli B; Shen S; O'Rourke J; Cone RE
    J Neuroimmunol; 2004 Aug; 153(1-2):40-9. PubMed ID: 15265662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation.
    Wang Y; Goldschneider I; O'Rourke J; Cone RE
    J Leukoc Biol; 2001 May; 69(5):741-6. PubMed ID: 11358982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation.
    Ashour HM; Niederkorn JY
    J Immunol; 2006 May; 176(10):5950-7. PubMed ID: 16670303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
    Farooq SM; Ashour HM
    Brain Behav Immun; 2014 Jan; 35():64-9. PubMed ID: 24095895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.